D926UL00001: A Phase IV, Open-Label, Single-Arm Study of Prophylaxis for Datopotamab Deruxtecan-related Stomatitis in Eligible Patients with Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer (TROPION-SWISH)

A Phase IV, Open-Label, Single-Arm Study of Prophylaxis for Datopotamab Deruxtecan-related Stomatitis in Eligible Patients with Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer (TROPION-SWISH)
Principal Investigator
Baka, Nadia
Phase
IV
Age Group
Adult
Applicable Disease Sites
Breast Cancer
Lung Cancer
Participating Institutions
Mary Babb Randolph Cancer Center
Contacts
Kaitlyn Hager
Research Nurse
Email:

View on ClinicalTrials.gov

Quick Search

Use the full search for additional searching options.